Piramal Pharma Limited (PPLPHARMA.BO)
INR 260.3
(-1.68%)
INR 260.3
(-1.68%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 81.71 Billion | 70.49 Billion | 65.03 Billion | 29.38 Billion |
| Cost of Revenue | 57.24 Billion | 32.11 Billion | 28.53 Billion | 12.78 Billion |
| Gross Profit | 24.47 Billion | 38.37 Billion | 36.5 Billion | 16.6 Billion |
| Operating Expenses | 19.91 Billion | 38.85 Billion | 32.85 Billion | 11.79 Billion |
| Selling, General and Administrative Expenses | 5.66 Billion | 5.52 Billion | 4.75 Billion | 1.81 Billion |
| Research and Development Expenses | 1 Billion | 863.6 Million | 1.28 Billion | 691.4 Million |
| Other Expenses | 13.23 Billion | 1.1 Billion | 2.35 Billion | 153 Million |
| Cost and Expenses | 77.15 Billion | 70.97 Billion | 61.38 Billion | 24.58 Billion |
| Operating Income | 4.55 Billion | -359.8 Million | 3.73 Billion | 5.5 Billion |
| Interest Expense | 4.48 Billion | 3.37 Billion | 1.88 Billion | 47.1 Million |
| Income Tax Expense | 1.61 Billion | 663.1 Million | 1.09 Billion | 1.15 Billion |
| Earnings before Tax | 1.19 Billion | -1.2 Billion | 4.84 Billion | 6.86 Billion |
| Net Income | 178.2 Million | -1.86 Billion | 3.75 Billion | 5.71 Billion |
| Earnings Per Share Basic | 0.14 | -1.53 | 3.11 | 4.70 |
| Earnings Per Share Diluted | 0.14 | -1.53 | 3.11 | 4.70 |
| Weighted Average Shares Outstanding | 1.27 Billion | 1.21 Billion | 1.2 Billion | 1.21 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Billion | 1.21 Billion | 1.2 Billion | 1.21 Billion |
| Gross Margin | 0.30 | 0.54 | 0.56 | 0.57 |
| EBIT Margin | 0.16 | 0.13 | 0.19 | 0.21 |
| Profit Margin | 0.00 | -0.03 | 0.06 | 0.19 |
| EBITDA | 13.05 Billion | 8.46 Billion | 12.1 Billion | 6.11 Billion |
| Earnings Before Tax Margin | 0.06 | -0.01 | 0.06 | 0.19 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 22.41 Billion | 19.51 Billion | 25.52 Billion | 81.71 Billion | 19.58 Billion | 19.11 Billion |
| Cost of Revenue | 7.96 Billion | 14.38 Billion | 17.04 Billion | 57.24 Billion | 6.75 Billion | 6.37 Billion |
| Gross Profit | 14.45 Billion | 5.12 Billion | 8.47 Billion | 24.47 Billion | 12.83 Billion | 12.73 Billion |
| Operating Expenses | 12.95 Billion | 4.92 Billion | 5.13 Billion | 19.91 Billion | 12.01 Billion | 11.92 Billion |
| Selling, General and Administrative Expenses | 5.44 Billion | 4.92 Billion | 5.13 Billion | - | 4.91 Billion | 4.91 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 12.95 Billion | 195.4 Million | 263.8 Million | 1.75 Billion | 615.1 Million | 491.9 Million |
| Cost and Expenses | 20.92 Billion | 19.31 Billion | 22.18 Billion | 77.15 Billion | 18.76 Billion | 18.3 Billion |
| Operating Income | 1.49 Billion | 199.4 Million | 3.33 Billion | 4.55 Billion | 820.5 Million | 811.3 Million |
| Interest Expense | 1.07 Billion | 1.06 Billion | 1.14 Billion | 4.48 Billion | 1.05 Billion | 1.09 Billion |
| Income Tax Expense | 975.3 Million | 435.6 Million | 1.26 Billion | 1.61 Billion | 92.5 Million | 345.4 Million |
| Earnings before Tax | 1.2 Billion | -674.8 Million | 2.15 Billion | 1.19 Billion | 193.6 Million | 395.6 Million |
| Net Income | 225.9 Million | -886.4 Million | 1.01 Billion | 178.2 Million | 101.1 Million | 50.2 Million |
| Earnings Per Share Basic | 0.17 | -0.67 | 0.77 | - | 0.08 | 0.04 |
| Earnings Per Share Diluted | 0.17 | -0.67 | 0.77 | - | 0.08 | 0.04 |
| Weighted Average Shares Outstanding | 1.32 Billion | 1.32 Billion | 1.27 Billion | 1.27 Billion | 1.32 Billion | 1.25 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.32 Billion | 1.32 Billion | 1.27 Billion | 1.27 Billion | 1.32 Billion | 1.25 Billion |
| Gross Margin | 0.64 | 0.26 | 0.33 | 0.30 | 0.66 | 0.67 |
| EBIT Margin | 0.19 | 0.10 | 0.21 | - | 0.18 | 0.17 |
| Profit Margin | 0.01 | -0.05 | 0.04 | 0.00 | 0.01 | 0.00 |
| EBITDA | 4.19 Billion | 2.04 Billion | 5.29 Billion | - | 3.43 Billion | 3.33 Billion |
| Earnings Before Tax Margin | 0.07 | 0.01 | 0.13 | 0.06 | 0.04 | 0.04 |
ATAP
CBSM
MHKI
GOGL
OILRF
CORA